The Australian High Court has ruled that an isolated gene sequence cannot be patented, as GenomeWeb has reported.

The case, D'Arcy v Myriad Genetics, was brought by a 69-year-old two-time breast cancer survivor against Myriad, which held a patent on mutations and polymorphisms in BRCA1 and BRCA2 that it licensed to Melbourne-based Genetic Technologies. But the court found that a gene cannot be patented.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.